Rosenblatt Securities Reiterates Buy Rating for Synopsys (NASDAQ:SNPS)

Synopsys (NASDAQ:SNPSGet Free Report)‘s stock had its “buy” rating reissued by equities researchers at Rosenblatt Securities in a research report issued on Friday,Benzinga reports. They currently have a $560.00 target price on the semiconductor company’s stock. Rosenblatt Securities’ price objective would suggest a potential upside of 27.29% from the stock’s previous close.

Several other research firms have also recently commented on SNPS. Wall Street Zen raised Synopsys from a “sell” rating to a “hold” rating in a research note on Saturday, December 13th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Synopsys in a research report on Thursday, January 22nd. Morgan Stanley boosted their target price on shares of Synopsys from $510.00 to $550.00 and gave the company an “overweight” rating in a research report on Friday, December 12th. Bank of America raised shares of Synopsys from an “underperform” rating to a “neutral” rating and cut their target price for the stock from $525.00 to $500.00 in a research note on Monday, December 8th. Finally, JPMorgan Chase & Co. lifted their price target on shares of Synopsys from $600.00 to $650.00 and gave the company an “overweight” rating in a research note on Thursday, December 11th. Nine research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $547.00.

Get Our Latest Analysis on SNPS

Synopsys Stock Performance

NASDAQ:SNPS opened at $439.94 on Friday. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.52 and a current ratio of 1.62. Synopsys has a fifty-two week low of $365.74 and a fifty-two week high of $651.73. The company has a 50 day simple moving average of $474.06 and a two-hundred day simple moving average of $482.90. The company has a market capitalization of $84.17 billion, a PE ratio of 55.06, a P/E/G ratio of 3.66 and a beta of 1.12.

Synopsys (NASDAQ:SNPSGet Free Report) last posted its quarterly earnings data on Wednesday, December 10th. The semiconductor company reported $2.90 EPS for the quarter, beating analysts’ consensus estimates of $2.79 by $0.11. The company had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.25 billion. Synopsys had a net margin of 18.89% and a return on equity of 7.89%. The company’s quarterly revenue was up 37.8% on a year-over-year basis. During the same period in the prior year, the firm posted $3.40 EPS. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. Research analysts anticipate that Synopsys will post 10.64 earnings per share for the current year.

Insider Transactions at Synopsys

In related news, insider Janet Lee sold 250 shares of Synopsys stock in a transaction that occurred on Monday, January 12th. The stock was sold at an average price of $530.00, for a total transaction of $132,500.00. Following the transaction, the insider owned 11,959 shares of the company’s stock, valued at $6,338,270. The trade was a 2.05% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CFO Shelagh Glaser sold 3,657 shares of the stock in a transaction on Friday, December 19th. The shares were sold at an average price of $460.77, for a total value of $1,685,035.89. Following the completion of the sale, the chief financial officer directly owned 17,842 shares of the company’s stock, valued at $8,221,058.34. The trade was a 17.01% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 4,157 shares of company stock worth $1,945,036 in the last 90 days. 0.62% of the stock is currently owned by company insiders.

Institutional Trading of Synopsys

Several institutional investors have recently made changes to their positions in SNPS. Sunbelt Securities Inc. raised its holdings in shares of Synopsys by 1,250.0% in the fourth quarter. Sunbelt Securities Inc. now owns 243 shares of the semiconductor company’s stock valued at $114,000 after purchasing an additional 225 shares during the last quarter. Cambient Family Office LLC purchased a new stake in Synopsys in the 4th quarter valued at about $3,294,000. Spinecap SAS bought a new position in shares of Synopsys during the 4th quarter worth approximately $11,347,000. Axxcess Wealth Management LLC lifted its position in shares of Synopsys by 39.4% during the 4th quarter. Axxcess Wealth Management LLC now owns 4,581 shares of the semiconductor company’s stock worth $2,152,000 after buying an additional 1,295 shares in the last quarter. Finally, Corient Private Wealth LLC boosted its stake in shares of Synopsys by 31.0% in the 4th quarter. Corient Private Wealth LLC now owns 35,155 shares of the semiconductor company’s stock worth $16,513,000 after buying an additional 8,322 shares during the last quarter. Institutional investors own 85.47% of the company’s stock.

Key Synopsys News

Here are the key news stories impacting Synopsys this week:

Synopsys Company Profile

(Get Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Featured Articles

Analyst Recommendations for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.